Bill of Health

SEPTEMBER 28, 2023

Despite having an outsized role in the discovery, development, manufacturing, and procurement of COVID-19 vaccines, therapeutics, and diagnostics, the federal government has generally not exercised any leverage in ensuring fair pricing and affordable access to these essential medical products.

COVID-19 208

COVID-19 COVID-19 Vaccine Pharmaceutical Industry Governance 208

Bill of Health

DECEMBER 14, 2022

Food and Drug Administration (FDA). For example, physicians and companies offering cytoplasmic and mitochondrial transfer have received Untitled Letters from the FDA. After receiving the letters, these individuals and entities have ceased to provide these techniques in the United States. using administrative law: (1) adapting the U.K.’s

FDA 208

FDA COVID-19 Vaccine COVID-19 Bioethics 208

Bill of Health

JANUARY 7, 2022

The American booster push was controversial, because the scientific evidence on the need for and effectiveness of boosters was limited, and the White House exerted an unprecedented level of pressure on the FDA and CDC’s ‘independent’ scientific review processes. Ultimately, both the FDA and CDC gave their blessing to boosters.

Public Health 340

Public Health FDA Governance COVID-19 Vaccine 340